Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status

Overview of attention for article published in Drugs, February 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 16,675 followers.

Therapies Directed Against B-Cells and Downstream Effectors in Generalized #Autoimmune Myasthenia Gravis: Current Status https://t.co/Nm3928lpjc

RT @DCTaronteV: #Research review finds promise with medication targeting #BCells and downstream effectors to treat #MyastheniaGravis. #neurology #neuroscience https://t.co/5RPqxIW1E8

#Research review finds promise with medication targeting #BCells and downstream effectors to treat #MyastheniaGravis. #neurology #neuroscience https://t.co/qQeKWd4A2d